Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:IPO NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIPORenaissance IPO ETF$49.99+0.6%$47.17$31.20▼$50.67$159.95M1.2244,108 shs98,946 shsTEMTempus AI$79.65+2.0%$65.12$31.36▼$91.45$13.84B5.0812.36 million shs7.63 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIPORenaissance IPO ETF+2.03%-1.27%+6.08%+13.65%+23.14%TEMTempus AI+2.40%+6.05%+35.30%+25.86%+45.38%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIPORenaissance IPO ETF$49.99+0.6%$47.17$31.20▼$50.67$159.95M1.2244,108 shs98,946 shsTEMTempus AI$79.65+2.0%$65.12$31.36▼$91.45$13.84B5.0812.36 million shs7.63 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIPORenaissance IPO ETF+2.03%-1.27%+6.08%+13.65%+23.14%TEMTempus AI+2.40%+6.05%+35.30%+25.86%+45.38%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIPORenaissance IPO ETF 2.68Moderate Buy$50.030.08% UpsideTEMTempus AI 2.54Moderate Buy$69.50-12.74% DownsideCurrent Analyst Ratings BreakdownLatest IPO, TEM, SSON, and RAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025TEMTempus AIHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$90.008/20/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$75.00 ➝ $85.008/12/2025TEMTempus AIMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$65.00 ➝ $68.008/8/2025TEMTempus AIBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$60.008/8/2025TEMTempus AIPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral8/8/2025TEMTempus AINeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.006/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $75.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$68.00 ➝ $70.00(Data available from 9/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/ATEMTempus AI$693.40M19.96N/AN/A$0.35 per share227.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIPORenaissance IPO ETFN/AN/A35.63∞N/AN/AN/AN/AN/ATEMTempus AI-$705.81M-$1.19N/AN/AN/A-20.98%-122.86%-18.09%11/3/2025 (Estimated)Latest IPO, TEM, SSON, and RAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025TEMTempus AI-$0.23-$0.22+$0.01-$0.25$296.84 million$314.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIPORenaissance IPO ETF$0.160.32%N/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIPORenaissance IPO ETFN/AN/AN/ATEMTempus AI2.581.541.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIPORenaissance IPO ETFN/ATEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipIPORenaissance IPO ETFN/ATEMTempus AI26.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIPORenaissance IPO ETFN/A3.20 millionN/ANot OptionableTEMTempus AI2,400173.73 million128.09 millionN/AIPO, TEM, SSON, and RAT HeadlinesRecent News About These CompaniesNorthwestern Medicine 1st to integrate Tempus AI co-pilot into EHRSeptember 4 at 7:01 PM | beckershospitalreview.comBNorthwestern Medicine integrates Tempus AI tech into electronic health recordsSeptember 4 at 7:01 PM | bizjournals.comTempus AI (TEM) Partners With Northwestern Medicine To Enhance AI-Powered Clinical CareSeptember 4 at 7:01 PM | finance.yahoo.comNorthwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR PlatformSeptember 4 at 7:01 PM | finance.yahoo.comTempus AI: Expansive Opportunity As Healthcare Becomes More Heavily ScrutinizedSeptember 4 at 3:04 PM | seekingalpha.comWhat's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?September 4 at 1:31 PM | zacks.comTempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare ConferenceSeptember 4 at 4:57 AM | theglobeandmail.comCritical Comparison: Tempus AI (NASDAQ:TEM) versus SOPHiA GENETICS (NASDAQ:SOPH)September 4 at 2:25 AM | americanbankingnews.comChicago tech entrepreneur Eric Lefkofsky has launched six unicorns, building a legacy far beyond GrouponSeptember 3 at 3:02 PM | chicagotribune.comTempus AI (NASDAQ:TEM) Now Covered by HC WainwrightSeptember 3 at 8:09 AM | marketbeat.com3 Heavily Shorted Stocks That Could Prove the Bears Wrong...September 2 at 2:17 PM | marketbeat.comRussell Investments Group Ltd. Buys New Holdings in Tempus AI, Inc. $TEMSeptember 2 at 3:46 AM | marketbeat.comHighTower Advisors LLC Buys New Position in Tempus AI, Inc. $TEMSeptember 2 at 3:39 AM | marketbeat.comTitleist Asset Management LLC Invests $2.36 Million in Tempus AI, Inc. $TEMAugust 31, 2025 | marketbeat.comTempus AI, Inc. (TEM) Expands into Digital Pathology with Paige AcquisitionAugust 31, 2025 | finance.yahoo.comTempus AI (NASDAQ:TEM) CEO Eric Lefkofsky Sells 332,500 SharesAugust 30, 2025 | marketbeat.comGordian Capital Singapore Pte Ltd Acquires Shares of 5,000 Tempus AI, Inc. $TEMAugust 30, 2025 | marketbeat.comEric Lefkofsky Sells 332,500 Shares of Tempus AI (NASDAQ:TEM) StockAugust 30, 2025 | insidertrades.comTempus AI, Inc. $TEM Stake Reduced by Comerica BankAugust 30, 2025 | marketbeat.comTempus AI, Inc. (TEM) Expands into Digital Pathology with Paige AcquisitionAugust 30, 2025 | insidermonkey.comTempus AI Stock Required A Tempered PositionAugust 29, 2025 | investors.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesIPO Market Stays Hot With These 2 Debuting StocksBy Dan Schmidt | August 11, 2025How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?By Jordan Chussler | August 14, 2025NVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025Deeply Undervalued, Micron Technologies Stock Isn’t Pricing in AIBy Thomas Hughes | August 14, 2025Microsoft Stock: Bullish Bets Pile Up Before SeptemberBy Chris Markoch | August 18, 2025IPO, TEM, SSON, and RAT Company DescriptionsRenaissance IPO ETF NYSEARCA:IPO$49.99 +0.28 (+0.56%) As of 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Renaissance IPO ETF (IPO) is an exchange-traded fund that is based on the FTSE Renaissance IPO index. The fund tracks a market cap-weighted index of recent US-listed IPOs. The fund acquires issues within 90 days or sooner after IPO and sells after 3 years. IPO was launched on Oct 14, 2013 and is managed by Renaissance.Tempus AI NASDAQ:TEM$79.65 +1.53 (+1.95%) As of 03:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Microsoft’s AI Push Beyond OpenAI Could Drive Next Breakout Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
